We're pleased to see a familiar face in our office these days -- our very first CGH patient, who kindly shared her original IVF success story with New Hope after the birth of her first child in 2011.
She first came to our clinic with a history of miscarriages -- one of which occurred after carrying for 18 weeks -- and turned off by aggressive protocols at other clinics. Attracted to New Hope's holistic approach to fertility care, she proceeded treatment with a Natural Cycle transfer -- the embryos collected from a few Mini-IVF™ cycles in order to increase her chances of collecting more than one healthy egg during treatment.
She opted for PGD with CGH testing in order to detect any genetic abnormalities that may be present, since she suffered from an autoimmune disorder. If genetic abnormalities exist within an embryo during IVF treatment, this can lead to miscarriage. She eventually became pregnant and Edward was born in December of 2011. She was the first case in which we used genetic testing to pick only the healthiest embryos for use during her minimal stimulation protocol.
Ms. CGH is back to try for a sister for Mr. Edward at the age of 44. We can't wait to help you again and add another baby to the New Hope Family!
CGH, or Comparative Genomic Hybridization, is a service we offer during treatment to make sure you’re getting the most from your cycle here at New Hope Fertility Center.
Although we’ve been offering PGD testing since our opening, we’ve partnered with Reprogenetics to ensure we're providing the latest in embryo-testing technology.
In the past, PGD was used solely for gender selection and finding specified chromosomal abnormalities. The current CGH testing is the most comprehensive test to detect significant genetic abnormalities in existence to date.
For more information on CGH testing, please visit us on the web to schedule a consultation.